-
1
-
-
79954867271
-
Drug enhanced autophagy to fight mutant protein overload
-
M. Mehrpour, and P. Codogno Drug enhanced autophagy to fight mutant protein overload J Hepatol 54 2011 1066 1068
-
(2011)
J Hepatol
, vol.54
, pp. 1066-1068
-
-
Mehrpour, M.1
Codogno, P.2
-
2
-
-
77954597127
-
An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis
-
T. Hidvegi, M. Ewing, P. Hale, C. Dippold, C. Beckett, and C. Kemp An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis Science 329 2010 229 232
-
(2010)
Science
, vol.329
, pp. 229-232
-
-
Hidvegi, T.1
Ewing, M.2
Hale, P.3
Dippold, C.4
Beckett, C.5
Kemp, C.6
-
3
-
-
0016246691
-
Carbamazepine for epilepsy. A controlled prospective evaluation
-
J.J. Cereghino, J.T. Brock, J.K. Van Meter JC Penry, L.D. Smith, and B.G. White Carbamazepine for epilepsy. A controlled prospective evaluation Neurology 24 1974 401 410
-
(1974)
Neurology
, vol.24
, pp. 401-410
-
-
Cereghino, J.J.1
Brock, J.T.2
Van Meter Jc Penry, J.K.3
Smith, L.D.4
White, B.G.5
-
4
-
-
0024418209
-
Treatment of cerebellar tremors with carbamazepine: A controlled trial with long-term follow-up
-
G.P. Sechi, M. Zuddas, M. Piredda, V. Agnetti, G. Sau, and M.L. Piras Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up Neurology 39 1989 1113 1115 (Pubitemid 19217487)
-
(1989)
Neurology
, vol.39
, Issue.8
, pp. 1113-1115
-
-
Sechi, G.P.1
Zuddas, M.2
Piredda, M.3
Agnetti, V.4
Sau, G.5
Piras, M.L.6
Tanca, S.7
Rosati, G.8
-
5
-
-
0020646939
-
Carbamazepine versus diphenyldantoin in the treatment of myotonia
-
G.P. Sechi, S. Traccis, L. Durelli, F. Monaco, and R. Mutani Carbamazepine versus diphenylhydantoin in the treatment of myotonia Eur Neurol 22 1983 113 118 (Pubitemid 13148247)
-
(1983)
European Neurology
, vol.22
, Issue.2
, pp. 113-118
-
-
Sechi, G.P.1
Traccis, S.2
Durelli, L.3
-
6
-
-
2542598418
-
Carbamazepine. Adverse effects
-
R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, 5th ed. Lippincott Williams and Wilkins Philadelphia
-
G.L. Holmes Carbamazepine. Adverse effects R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, Antiepileptic drugs 5th ed. 2002 Lippincott Williams and Wilkins Philadelphia 285 297
-
(2002)
Antiepileptic Drugs
, pp. 285-297
-
-
Holmes, G.L.1
-
7
-
-
0026686095
-
Acute toxic reaction to carbamazepine: Clinical effects and serum concentrations
-
J. Tibbals Acute toxic reaction to carbamazepine: clinical effects and serum concentrations J Pediatr 121 1992 295 299
-
(1992)
J Pediatr
, vol.121
, pp. 295-299
-
-
Tibbals, J.1
-
8
-
-
0034863166
-
COPD: Management of acute exacerbations and chronic stable disease
-
M.H. Hunter, and D.E. King COPD: management of acute exacerbations and chronic stable disease Am Fam Physician 64 2001 603 613
-
(2001)
Am Fam Physician
, vol.64
, pp. 603-613
-
-
Hunter, M.H.1
King, D.E.2
-
9
-
-
77953812401
-
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation
-
T. Bachetti, E. Di Zanni, P. Balbi, P. Bocca, I. Prigione, and G.A. Deiana In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation Exp Cell Res 316 2010 2152 2165
-
(2010)
Exp Cell Res
, vol.316
, pp. 2152-2165
-
-
Bachetti, T.1
Di Zanni, E.2
Balbi, P.3
Bocca, P.4
Prigione, I.5
Deiana, G.A.6
-
10
-
-
77649271362
-
Ceftriaxone has a therapeutic role in Alexander disease
-
G.P. Sechi, M. Matta, G.A. Deiana, P. Balbi, T. Bachetti, and E. Di Zanni Ceftriaxone has a therapeutic role in Alexander disease Prog Neuropsychopharmacol Biol Psychiatry 34 2010 416 417
-
(2010)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.34
, pp. 416-417
-
-
Sechi, G.P.1
Matta, M.2
Deiana, G.A.3
Balbi, P.4
Bachetti, T.5
Di Zanni, E.6
|